# A Single-arm Clinical Trial Using Patient-derived Tumor Tissue Fragment Models for Drug Sensitivity Testing to Guide Treatment in Previously Treated Cancers

> **NCT07264803** · PHASE2 · RECRUITING · sponsor: **Qilu Hospital of Shandong University** · enrollment: 35 (estimated)

## Conditions studied

- Solid Tumor Malignancies
- Solid Tumor Cancer

## Interventions

- **OTHER:** PDTF-Guided Personalized Treatment
- **OTHER:** PDTF-Guided Personalized Treatment

## Key facts

- **NCT ID:** NCT07264803
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-01
- **Primary completion:** 2027-12-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07264803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07264803, "A Single-arm Clinical Trial Using Patient-derived Tumor Tissue Fragment Models for Drug Sensitivity Testing to Guide Treatment in Previously Treated Cancers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07264803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*